Incidence of polyp formation following bariatric surgery.


Journal

Surgery for obesity and related diseases : official journal of the American Society for Bariatric Surgery
ISSN: 1878-7533
Titre abrégé: Surg Obes Relat Dis
Pays: United States
ID NLM: 101233161

Informations de publication

Date de publication:
10 2021
Historique:
received: 09 04 2020
revised: 29 04 2021
accepted: 12 06 2021
pubmed: 24 7 2021
medline: 26 10 2021
entrez: 23 7 2021
Statut: ppublish

Résumé

Multiple studies have linked obesity to an increased risk of cancer. The correlation is so strong that the national cancer prevention guidelines recommend weight loss for patients with obesity to reduce their risk of cancer. Bariatric surgery has been shown to be very effective in sustained weight loss. However, there have been mixed findings about bariatric surgery and its effects on the risk of colorectal cancer. This study sought to examine bariatric surgery patients and their risk of pre-cancerous or cancerous polyps to elucidate any risk factors or associations between bariatric surgery and colorectal cancer. A retrospective review of the academic medical center's bariatric surgery database was performed from January 2010 to January 2017. Patients who underwent medical or surgical weight loss and had a subsequent colonoscopy were included in the study. Positive colonoscopy findings were described as malignant or premalignant polyps. A total of 1777 patients were included, with 1360 in the medical group and 417 in the surgical group. Data analysis included patient demographics, co-morbidities, procedure performed, surgical approach, weight loss, and colonoscopy findings. A multivariate analysis was used to determine whether an association exists between weight loss and incidence of colorectal polyps, and if so, whether the association different for medical versus surgical weight loss. A higher percentage of body mass index (BMI) reduction was seen in the surgical group. An overall comparison showed average reductions in BMI of 27.7% in the surgical group and 3.5% in the medical group (P < .0001). Patients with the greatest reduction in BMI, regardless of medical or surgical therapy, showed a lower incidence of precancerous and cancerous polyps (P = .041). This study offers a unique approach in examining the incidence of colorectal polyps related to obesity. Patients with the greatest reduction in their BMI, more common in the surgical group, had a lower incidence of precancerous and cancerous polyps.

Sections du résumé

BACKGROUND
Multiple studies have linked obesity to an increased risk of cancer. The correlation is so strong that the national cancer prevention guidelines recommend weight loss for patients with obesity to reduce their risk of cancer. Bariatric surgery has been shown to be very effective in sustained weight loss. However, there have been mixed findings about bariatric surgery and its effects on the risk of colorectal cancer.
OBJECTIVE
This study sought to examine bariatric surgery patients and their risk of pre-cancerous or cancerous polyps to elucidate any risk factors or associations between bariatric surgery and colorectal cancer.
SETTING
A retrospective review of the academic medical center's bariatric surgery database was performed from January 2010 to January 2017. Patients who underwent medical or surgical weight loss and had a subsequent colonoscopy were included in the study. Positive colonoscopy findings were described as malignant or premalignant polyps.
METHODS
A total of 1777 patients were included, with 1360 in the medical group and 417 in the surgical group. Data analysis included patient demographics, co-morbidities, procedure performed, surgical approach, weight loss, and colonoscopy findings. A multivariate analysis was used to determine whether an association exists between weight loss and incidence of colorectal polyps, and if so, whether the association different for medical versus surgical weight loss.
RESULTS
A higher percentage of body mass index (BMI) reduction was seen in the surgical group. An overall comparison showed average reductions in BMI of 27.7% in the surgical group and 3.5% in the medical group (P < .0001). Patients with the greatest reduction in BMI, regardless of medical or surgical therapy, showed a lower incidence of precancerous and cancerous polyps (P = .041).
CONCLUSION
This study offers a unique approach in examining the incidence of colorectal polyps related to obesity. Patients with the greatest reduction in their BMI, more common in the surgical group, had a lower incidence of precancerous and cancerous polyps.

Identifiants

pubmed: 34294588
pii: S1550-7289(21)00302-6
doi: 10.1016/j.soard.2021.06.005
pii:
doi:

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

1773-1779

Informations de copyright

Copyright © 2021 American Society for Bariatric Surgery. Published by Elsevier Inc. All rights reserved.

Auteurs

Andrew C Droney (AC)

Department of Surgery, Geisinger Wyoming Valley Medical Center, Wilkes Barre, Pennsylvania. Electronic address: acdroney@geisinger.edu.

William Sellers (W)

Department of Surgery, Geisinger Wyoming Valley Medical Center, Wilkes Barre, Pennsylvania.

Anjuli Gupta (A)

Department of Surgery, Geisinger Wyoming Valley Medical Center, Wilkes Barre, Pennsylvania.

Kelly Rose Johnson (KR)

Department of Surgery, Geisinger Wyoming Valley Medical Center, Wilkes Barre, Pennsylvania.

Marcus Fluck (M)

Department of Surgery, Geisinger Medical Center, Danville, Pennsylvania.

Anthony Petrick (A)

Department of Surgery, Geisinger Medical Center, Danville, Pennsylvania.

Joseph Bannon (J)

Department of Surgery, Geisinger Community Medical Center, Scranton, Pennsylvania.

Thomas Erchinger (T)

Department of Surgery, Geisinger Wyoming Valley Medical Center, Wilkes Barre, Pennsylvania.

Bogdan Protyniak (B)

Department of Surgery, Geisinger Wyoming Valley Medical Center, Wilkes Barre, Pennsylvania.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH